Literature DB >> 19402988

Pulmonary involvement and leptospirosis, Greece.

Anna Papa, Dionysia Theoharidou, Antonis Antoniadis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19402988      PMCID: PMC2687020          DOI: 10.3201/eid1505.080270

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Since the leptospirosis outbreak associated with pulmonary hemorrhage in Nicaragua in 1995 (), pulmonary manifestations of leptospirosis are often recognized in many countries; reported incidence has ranged from 20% to 70% (–). The severe pulmonary form of leptospirosis is accompanied by pulmonary hemorrhage, which directly results in high death rates (,). In Greece (population 11 million), leptospirosis cases in humans occur every year, usually from June to November (summer and autumn), with a peak in August. The annual incidence rate of the disease is 3 cases per 1 million population (). Clinical presentation varies from a flu-like syndrome to Weil disease, which includes jaundice, renal failure, and hemorrhagic complications. Studies on leptospirosis in Greece have been limited, and no reports have focused on pulmonary involvement. During 1998–2007, we tested samples from 650 patients with suspected leptospirosis or hemorrhagic fever with renal syndrome (i.e., hantavirus infection). Various hospitals of northern Greece sent these samples to our laboratory (a World Health Organization Collaborating Center for Reference and Research on Arboviruses and Hemorrhagic Fever) for analysis. Because both diseases are endemic to Greece and have similar clinical, epidemiologic, and seasonal characteristics (), all samples sent to our laboratory for testing either for leptospirosis or for hantavirus infection are always tested for both (). Leptospirosis was confirmed for 123 patients, 10 (8.1%) of whom died (Table). For 72 case-patients, paired samples were available. A commercial ELISA (Leptospira IgG/IgM, Institute Virion/Serion GmbH, Würzburg, Germany) was used to detect immunoglobulin (Ig) G and IgM against Leptospira spp.. A nested PCR, which amplifies a 289-bp fragment of the 16S rDNA gene, was used to detect bacterial DNA (). IgM concentrations >20 U/mL indicated acute infection. Samples with borderline results were tested in parallel with a second sample taken from the patient 1 week later. IgG concentrations were considered only for paired samples, and a case was considered as acute leptospirosis when a >4-fold titer rise of IgG, or IgG seroconversion, was detected. When samples were taken before the sixth day of illness, initial diagnosis was achieved by PCR. In 6 of 10 fatal cases, leptospirosis was diagnosed only by PCR because antibodies were not detectable. Epidemiologic and clinical information for patients was collected from chart review, following a protocol approved by the medical school review board.
Table

Leptospirosis cases and pulmonary involvement, Greece, 1998–2007

YearNo. cases (no. fatal cases)No. cases with pulmonary involvement (no. fatal cases)
199812 (0)0 (0)
19999 (2)3 (0)
20007 (1)1 (0)
200111 (0)1 (0)
200213 (2)4 (2)
200313 (1)6 (1)
200420 (3)10 (3)
200514 (1)3 (1)
2006
17 (0)
5 (0)
20077 (0)2 (0)
Total123 (10)35 (7)
All 123 patients resided in northern Greece. Most (82.1%) were male; patients were 6–83 years of age (median 51 years). Fifty-two patients were farmers; 9 were sewer workers; and 6 and 2 patients, respectively, reported gardening and other recreational exposures before becoming ill. Cases occurred in all months; 27% occurred in August. Fever, as well as elevated levels of serum urea and creatinine, occurred in all patients; 55 (44.7%) had jaundice, and 46 (37.4%) had thrombocytopenia. Weil disease was present in 27 (22%). In our case-series, jaundice appeared to be a common sign, in contrast to recent studies in other countries in which the icteric form of the disease was observed in only 10% of cases (). Median age of the 10 patients who died was 50 years (range 39–78 years). Half of the patients who died had the icteric form of the disease, 4 had the typical signs and symptoms of Weil disease, and 1 had central nervous system involvement. Thirty-five (28.5%) patients had pulmonary signs and symptoms, either when admitted to the hospital or during hospitalization. Eight of these had acute respiratory distress syndrome, 6 had multiple organ dysfunction syndrome, and 6 had acute respiratory insufficiency; the remainder had hemoptysis and/or dyspnea, according clinician notes in the medical charts. More than half of the patients had abnormal radiographic findings, mainly bilateral bronchoalveolar infiltrations. Seven (20%) of the 35 case-patients with pulmonary involvement died, a significantly higher death rate than that for case-patients without pulmonary involvement (3.4%, p<0.01). Respiratory symptoms were recognized during the first phase of the disease, as other studies have reported (). We found no significant difference in death rates between males and females (p = 0.629). Pulmonary involvement seems to be common and associated with a high death rate for patients with severe leptospirosis cases in our setting. Clinicians in Greece should include leptospirosis in the differential diagnosis of syndromes with associated pulmonary manifestations.
  10 in total

Review 1.  Leptospirosis: a zoonotic disease of global importance.

Authors:  Ajay R Bharti; Jarlath E Nally; Jessica N Ricaldi; Michael A Matthias; Monica M Diaz; Michael A Lovett; Paul N Levett; Robert H Gilman; Michael R Willig; Eduardo Gotuzzo; Joseph M Vinetz
Journal:  Lancet Infect Dis       Date:  2003-12       Impact factor: 25.071

Review 2.  The globalization of leptospirosis: worldwide incidence trends.

Authors:  Georgios Pappas; Photini Papadimitriou; Vasiliki Siozopoulou; Leonidas Christou; Nikolaos Akritidis
Journal:  Int J Infect Dis       Date:  2007-12-04       Impact factor: 3.623

Review 3.  Pathology and pathophysiology of pulmonary manifestations in leptospirosis.

Authors:  Marisa Dolhnikoff; Thais Mauad; Eduardo P Bethlem; Carlos Roberto Ribeiro Carvalho
Journal:  Braz J Infect Dis       Date:  2007-02       Impact factor: 1.949

Review 4.  Pulmonary manifestations of leptospirosis.

Authors:  K M O'Neil; L S Rickman; A A Lazarus
Journal:  Rev Infect Dis       Date:  1991 Jul-Aug

5.  A rapid and quantitative method for the detection of Leptospira species in human leptospirosis.

Authors:  Fabrice Merien; Denis Portnoi; Pascale Bourhy; Françoise Charavay; Alain Berlioz-Arthaud; Guy Baranton
Journal:  FEMS Microbiol Lett       Date:  2005-08-01       Impact factor: 2.742

6.  Respiratory manifestations of leptospirosis: a retrospective study.

Authors:  P Tattevin; G Léveiller; R Flicoteaux; S Jauréguiberry; Y Le Tulzo; M Dupont; C Arvieux; C Michelet
Journal:  Lung       Date:  2005 Jul-Aug       Impact factor: 2.584

7.  Comparison of the clinical and serologic diagnosis of haemorrhagic fever with renal syndrome (HFRS) and leptospirosis.

Authors:  A Antoniadis; S Alexiou-Daniel; L Fidani; E F Bautz
Journal:  Eur J Epidemiol       Date:  1995-02       Impact factor: 8.082

8.  Epidemic leptospirosis associated with pulmonary hemorrhage-Nicaragua, 1995.

Authors:  R T Trevejo; J G Rigau-Pérez; D A Ashford; E M McClure; C Jarquín-González; J J Amador; J O de los Reyes; A Gonzalez; S R Zaki; W J Shieh; R G McLean; R S Nasci; R S Weyant; C A Bolin; S L Bragg; B A Perkins; R A Spiegel
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

9.  Retrospective serological and genetic study of the distribution of hantaviruses in Greece.

Authors:  A Papa; A M Johnson; P C Stockton; M D Bowen; C F Spiropoulou; S Alexiou-Daniel; T G Ksiazek; S T Nichol; A Antoniadis
Journal:  J Med Virol       Date:  1998-08       Impact factor: 2.327

10.  Leptospirosis-associated severe pulmonary hemorrhagic syndrome, Salvador, Brazil.

Authors:  Edilane L Gouveia; John Metcalfe; Ana Luiza F de Carvalho; Talita S F Aires; José Caetano Villasboas-Bisneto; Adriano Queirroz; Andréia C Santos; Kátia Salgado; Mitermayer G Reis; Albert I Ko
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

  10 in total
  8 in total

1.  Determinants of mortality and impact of therapy in patients with leptospirosis admitted for intensive care in a Sri Lankan hospital--a three year retrospective study.

Authors:  P N Weeratunga; S Fernando; S Sriharan; M Gunawardena; S Wijenayake
Journal:  Pathog Glob Health       Date:  2015       Impact factor: 2.894

2.  An Improved Enzyme-Linked Immunoassay for the Detection of Leptospira-Specific Antibodies.

Authors:  Hua-Wei Chen; Heather Lukas; Kira Becker; Giulia Weissenberger; Eric S Halsey; Carolina Guevara; Enrique Canal; Eric Hall; Ryan C Maves; Drake H Tilley; Lynn Kuo; Tadeusz J Kochel; Wei-Mei Ching
Journal:  Am J Trop Med Hyg       Date:  2018-06-21       Impact factor: 2.345

3.  Developing a clinically relevant classification to predict mortality in severe leptospirosis.

Authors:  Senaka Rajapakse; Chaturaka Rodrigo; Rashan Haniffa
Journal:  J Emerg Trauma Shock       Date:  2010-07

4.  Emergence of novel Leptospira serovars: a need for adjusting vaccination policies for dogs?

Authors:  Z J Arent; S Andrews; K Adamama-Moraitou; C Gilmore; D Pardali; W A Ellis
Journal:  Epidemiol Infect       Date:  2012-09-24       Impact factor: 4.434

Review 5.  Global Morbidity and Mortality of Leptospirosis: A Systematic Review.

Authors:  Federico Costa; José E Hagan; Juan Calcagno; Michael Kane; Paul Torgerson; Martha S Martinez-Silveira; Claudia Stein; Bernadette Abela-Ridder; Albert I Ko
Journal:  PLoS Negl Trop Dis       Date:  2015-09-17

6.  Efficacy of the Rabbit Polyclonal Anti-leptospira Antibody against Homotype or Heterotype Leptospira Infection in Hamster.

Authors:  Xuemin Jin; Wenlong Zhang; Zhuang Ding; Hai Wang; Dianjun Wu; Xufeng Xie; Tao Lin; Yunhe Fu; Naisheng Zhang; Yongguo Cao
Journal:  PLoS Negl Trop Dis       Date:  2016-12-27

7.  Risk factors and predictors of severe leptospirosis in New Caledonia.

Authors:  Sarah Tubiana; Marc Mikulski; Jérôme Becam; Flore Lacassin; Patrick Lefèvre; Ann-Claire Gourinat; Cyrille Goarant; Eric D'Ortenzio
Journal:  PLoS Negl Trop Dis       Date:  2013-01-10

8.  Estimating the Burden of Leptospirosis among Febrile Subjects Aged below 20 Years in Kampong Cham Communities, Cambodia, 2007-2009.

Authors:  Sopheak Hem; Sowath Ly; Irene Votsi; Florian Vogt; Nima Asgari; Philippe Buchy; Seiha Heng; Mathieu Picardeau; Touch Sok; Sovann Ly; Rekol Huy; Bertrand Guillard; Simon Cauchemez; Arnaud Tarantola
Journal:  PLoS One       Date:  2016-04-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.